Alyssa Marino

Alyssa Marino is a seasoned professional in the field of clinical operations, currently serving as a Clinical Operations Consultant at Clasp Therapeutics since July 2024. Previously, Alyssa held the position of VP, Head of Clinical Operations at Marengo Therapeutics from March 2022 to April 2024. Additional experience includes serving as Senior Director of Clinical Operations at H3 Biomedicine, Director of Clinical Operations at Celyad, and Lead Clinical Trial Leader at Novartis, among other roles in prominent organizations such as EMD Serono, Genzyme, Organogenesis, and Harvard Clinical Research Institute. Alyssa's extensive background encompasses various leadership roles that leverage expertise in clinical trial management and operations. Educational credentials include a degree from Boston College.